Patent expiry dates for biologicals: 2017 update - GaBI Journal
Silver Spring-based United Therapeutics settles patent dispute over Remodulin generic with Teva Pharmaceuticals - Washington Business Journal
TEVA PHARMS USA drug pipeline, international patents
Time for a Turnaround at Teva Pharmaceuticals Industries Ltd? | The Motley Fool
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
List - 54 Drug Patents Expiring in 2024 - GreyB
Corcept Therapeutics: Far More Constructive With Korlym Resolve (NASDAQ:CORT) | Seeking Alpha
Generic drugs: Navigating the Patent Cliff: The Rise of Generic Drugs - FasterCapital
Idea of the Week: Teva Pharmaceutical—The Top Leader in Generic Drugs | Bondsupermart
Skinny labelling of generics: the beginning of the end for this practice? - Pharma Technology Focus | Issue 104 | March 2021
Drug Patent Expirations and the “Patent Cliff”
Teva Pharmaceuticals - Wikipedia
Teva Pharma Plunges After Two U.S. Copaxone Patents Invalidated | Investor's Business Daily
Global Generic Drugs Market Report 2022: Rapid Patent Expiry of Branded Drugs Creates Opportunities
Teva: Warren Buffett Likely Made A Mistake Selling Shares | Seeking Alpha
List - 91 Drug Patents that are Expiring between 2020 to 2022 - GreyB
Several blockbuster patents to expire in 2023 - BioStock
Patents mean big business to big pharma
Teva generics revenue by region 2016-2023 | Statista
TEVA BRANDED PHARM drug patent status, global patents
TEVA drug pipeline, global patents
Loss of Patent Protection to Drag Pfizer's Top Line
PATENT EXPIRY DATES 1/3 | New Drug Approvals
Patent expiry dates for biologicals: 2018 update - GaBI Journal
